Published in J Urol on July 17, 2009
CLamp vs Off Clamp Kidney During Partial Nephrectomy (CLOCK) | NCT02287987
An Arterial Based Complexity (ABC) Scoring System to Assess the Morbidity Profile of Partial Nephrectomy. Eur Urol (2015) 3.17
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol (2011) 2.87
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol (2011) 2.22
Comparative analysis of minimally invasive partial nephrectomy techniques in the treatment of localized renal tumors. Urology (2012) 2.22
Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology (2011) 2.20
Robotic-assisted versus traditional laparoscopic partial nephrectomy: comparison of outcomes and evaluation of learning curve. Urology (2011) 1.98
Interobserver variability of R.E.N.A.L., PADUA, and centrality index nephrometry score systems. World J Urol (2014) 1.55
Assessing the burden of complications after surgery for clinically localized kidney cancer by age and comorbidity status. Urology (2014) 1.54
Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy. J Urol (2013) 1.53
Renal functional and perioperative outcomes of off-clamp versus clamped robot-assisted partial nephrectomy: matched cohort study. Urology (2012) 1.52
Intraoperative mannitol use does not improve long-term renal function outcomes after minimally invasive partial nephrectomy. Urology (2012) 1.50
A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy. Eur Urol (2015) 1.50
Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology (2013) 1.49
Understanding criteria for surveillance of patients with a small renal mass. Urology (2012) 1.48
Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology (2011) 1.46
Robot-assisted partial nephrectomy: a large single-institutional experience. Urology (2010) 1.45
Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology (2014) 1.43
Novel kidney segmentation system to describe tumour location for nephron-sparing surgery. World J Urol (2014) 1.39
Comparison of the trifecta outcomes of robotic and open nephron-sparing surgeries performed in the robotic era of a single institution. Springerplus (2015) 1.39
Association between R.E.N.A.L. nephrometry score and perioperative outcomes following open partial nephrectomy under cold ischemia. Can Urol Assoc J (2014) 1.38
Outcomes of partial nephrectomy in patients who meet percutaneous ablation criteria. Cent European J Urol (2015) 1.19
The association between renal tumour scoring systems and ischemia time during open partial nephrectomy. Can Urol Assoc J (2013) 1.08
External validation of the preoperative anatomical classification for prediction of complications related to nephron-sparing surgery. World J Urol (2010) 1.08
Transition from laparoscopic to robotic partial nephrectomy: the learning curve for an experienced laparoscopic surgeon. JSLS (2011) 1.02
The UREThRAL stricture score: A novel method for describing anterior urethral strictures. Can Urol Assoc J (2012) 1.00
Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score. World J Urol (2012) 0.99
Validation of the preoperative aspects and dimensions used for an anatomical (PADUA) score in a robot-assisted partial nephrectomy series. World J Urol (2011) 0.99
Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up. Urol Oncol (2011) 0.97
Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? J Urol (2012) 0.96
Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education. World J Urol (2015) 0.96
The effects of warm ischaemia time on renal function after laparoscopic partial nephrectomy in patients with normal contralateral kidney. World J Urol (2011) 0.95
A comparison of robotic, laparoscopic and open partial nephrectomy. JSLS (2013) 0.95
Open versus laparoscopic partial nephrectomy for clinical T1a renal masses: a matched-pair comparison of 280 patients with TRIFECTA outcomes (RECORd Project). World J Urol (2013) 0.94
Prediction of complications after partial nephrectomy by RENAL nephrometry score. Ann R Coll Surg Engl (2014) 0.94
Laparoscopic partial nephrectomy with diode laser: a promising technique. Photomed Laser Surg (2014) 0.93
Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours. Can Urol Assoc J (2014) 0.92
Laparoscopic versus open partial nephrectomy for clinical T1 renal masses: no impact of surgical approach on perioperative complications and long-term postoperative quality of life. World J Urol (2014) 0.92
Significant impact of R.E.N.A.L. nephrometry score on changes in postoperative renal function early after robot-assisted partial nephrectomy. Int J Clin Oncol (2014) 0.92
Correlation of the RENAL nephrometry score with warm ischemia time after robotic partial nephrectomy. World J Urol (2012) 0.91
Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy. World J Urol (2011) 0.91
Selective clamping under the usage of near-infrared fluorescence imaging with indocyanine green in robot-assisted partial nephrectomy: a single-surgeon matched-pair study. World J Urol (2013) 0.90
Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int (2013) 0.90
Expanding utilization of robotic partial nephrectomy for clinical T1b and complex T1a renal masses. World J Urol (2013) 0.90
Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol (2014) 0.89
Laparoscopic and open partial nephrectomy: complication comparison using the Clavien system. JSLS (2012) 0.88
Association of clinical and radiographic features with perinephric "sticky" fat. J Endourol (2012) 0.87
Surgical Treatment of Tumors Involving Kidneys With Fusion Anomalies: A Contemporary Series. Urology (2016) 0.87
Radiogenomics of clear cell renal cell carcinoma: preliminary findings of The Cancer Genome Atlas-Renal Cell Carcinoma (TCGA-RCC) Imaging Research Group. Abdom Imaging (2015) 0.87
Active surveillance of small renal masses. Nat Rev Urol (2013) 0.86
Robotic partial nephrectomy versus laparoscopic partial nephrectomy: a single laparoscopic trained surgeon's experience in the development of a robotic partial nephrectomy program. World J Urol (2011) 0.86
Is there a role for neoadjuvant targeted therapy to downsize primary tumors for organ sparing strategies in renal cell carcinoma? Int J Surg Oncol (2012) 0.85
The association between renal tumour scoring system components and complications of partial nephrectomy. Can Urol Assoc J (2015) 0.84
Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy. Urology (2014) 0.84
Impact of Robotic Fellowship Experience on Perioperative Outcomes of Robotic-Assisted Laparoscopic Partial Nephrectomy. Curr Urol (2016) 0.84
Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches. Int J Clin Oncol (2015) 0.84
Comparison of surgical, functional, and oncological outcomes of open and robot-assisted partial nephrectomy. J Minim Access Surg (2015) 0.82
Robot-assisted partial nephrectomy in contemporary practice. Front Oncol (2013) 0.82
Stage T3a renal cell carcinoma: staging accuracy of CT for sinus fat, perinephric fat or renal vein invasion. Br J Radiol (2015) 0.82
Mini-flank supra-12th rib incision for open partial nephrectomy compared with laparoscopic partial nephrectomy and traditional open partial nephrectomy. PLoS One (2014) 0.82
Kidney cancer: zero-ischemia partial nephrectomy--further evaluations are needed. Nat Rev Urol (2011) 0.82
Achievement of trifecta in minimally invasive partial nephrectomy correlates with functional preservation of operated kidney: a multi-institutional assessment using MAG3 renal scan. World J Urol (2015) 0.82
Simplified zero ischemia in robot assisted partial nephrectomy: initial yonsei experience. Korean J Urol (2013) 0.82
Comparison of diameter-axial-polar nephrometry and RENAL nephrometry score for treatment decision-making in patients with small renal mass. Int J Clin Oncol (2014) 0.81
Laparoscopic partial nephrectomy: risk stratification according to patient and tumor characteristics. World J Urol (2012) 0.81
Current controversies and challenges in robotic-assisted, laparoscopic, and open partial nephrectomies. World J Urol (2014) 0.81
Urine aquaporin 1 and perilipin 2 differentiate renal carcinomas from other imaged renal masses and bladder and prostate cancer. Mayo Clin Proc (2015) 0.81
Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer. Biologics (2012) 0.80
The Zhongshan score: a novel and simple anatomic classification system to predict perioperative outcomes of nephron-sparing surgery. Medicine (Baltimore) (2015) 0.80
Serum and urine biomarkers for human renal cell carcinoma. Dis Markers (2015) 0.80
Risk factors for postoperative hemorrhage after partial nephrectomy. Korean J Urol (2014) 0.80
The nephrometry score: is it effective for predicting perioperative outcome during robot-assisted partial nephrectomy? Korean J Urol (2014) 0.80
R.E.N.A.L. nephrometry score predicts postoperative recurrence of localized renal cell carcinoma treated by radical nephrectomy. Int J Clin Oncol (2015) 0.79
Robot-assisted laparoendoscopic single-site partial nephrectomy with the novel da vinci single-site platform: initial experience. Korean J Urol (2014) 0.79
The renal tumor morphological characteristics that affect surgical planning for laparoscopic or open partial nephrectomy. Nagoya J Med Sci (2015) 0.79
Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing. Adv Urol (2012) 0.79
Perihilar branching patterns of renal artery and extrarenal length of arterial branches and tumour-feeding arteries on multidetector CT angiography. Br J Radiol (2013) 0.79
Perioperative outcomes of robotic partial nephrectomy for intrarenal tumors. J Endourol (2014) 0.79
Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis. Urol Oncol (2014) 0.79
Open mini-flank partial nephrectomy: an essential contemporary operation. Korean J Urol (2014) 0.79
External validation of the RENAL nephrometry score nomogram for predicting high-grade renal cell carcinoma in solid, enhancing, and small renal masses. World J Urol (2013) 0.78
Factors that affect proportional glomerular filtration rate after minimally invasive partial nephrectomy. J Endourol (2013) 0.78
Morphometric profile of the localised renal tumors managed either by open or robot-assisted nephron-sparing surgery: the impact of scoring systems on the decision making process. BMC Urol (2013) 0.78
Laparoscopic partial nephrectomy for >4 cm renal masses. Can Urol Assoc J (2013) 0.78
Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas. Korean J Urol (2015) 0.78
Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesions. Urol Oncol (2014) 0.78
Comparison of robotic and open partial nephrectomy: Single-surgeon matched cohort study. Can Urol Assoc J (2014) 0.78
Comparison of selective parenchymal clamping to hilar clamping during robotic-assisted laparoscopic partial nephrectomy. Urology (2013) 0.78
Predicting outcomes in partial nephrectomy: is the renal score useful? Int Braz J Urol (2017) 0.78
Zonal NephRo Score: external validation for predicting complications after open partial nephrectomy. World J Urol (2015) 0.78
Application of modified R.E.N.A.L. nephrometry score system in evaluating the retroperitoneal partial nephrectomy for T1 renal cell carcinoma. Int J Clin Exp Med (2015) 0.78
Cost-effectiveness of robot-assisted partial nephrectomy for the prevention of perioperative complications. World J Urol (2015) 0.78
Postoperative drainage does not prevent complications after robotic partial nephrectomy. World J Urol (2015) 0.77
Impact of tumor histology and grade on treatment success of percutaneous renal cryoablation. World J Urol (2016) 0.77
A propensity-score matched comparison of perioperative and early renal functional outcomes of robotic versus open partial nephrectomy. PLoS One (2014) 0.77
Kidney cancer focal cryoablation trend: does location or approach matter? World J Urol (2015) 0.77
Is anatomic complexity associated with renal tumor growth kinetics under active surveillance? Urol Oncol (2015) 0.77
The association between the anatomical features of renal tumours and the functional outcomes of robot-assisted partial nephrectomy. Can Urol Assoc J (2014) 0.77
Kidney cancer in 2011: objectifying risk for localized renal masses. Nat Rev Urol (2011) 0.77
Guideline for management of the clinical T1 renal mass. J Urol (2009) 8.26
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol (2013) 4.78
The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol (2006) 3.88
Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol (2008) 3.46
Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J Clin Oncol (2009) 3.38
Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer (2011) 3.13
Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. J Clin Oncol (2012) 3.03
Cutaneous metastases from genitourinary malignancies. Urology (2004) 2.97
Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. Eur Urol (2011) 2.87
Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer (2008) 2.75
Academic ranking score: a publication-based reproducible metric of thought leadership in urology. Eur Urol (2011) 2.51
Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score. Eur Urol (2011) 2.22
Prevalence of baseline chronic kidney disease in patients presenting with solid renal tumors. Urology (2011) 2.20
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. Int J Radiat Oncol Biol Phys (2005) 2.08
Promoter hypermethylation profile of kidney cancer. Clin Cancer Res (2004) 2.02
Small renal masses progressing to metastases under active surveillance: a systematic review and pooled analysis. Cancer (2011) 1.98
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer (2008) 1.98
Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol (2012) 1.95
Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. BJU Int (2011) 1.78
Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma. J Urol (2012) 1.78
Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology (2010) 1.77
The expanding role of partial nephrectomy: a critical analysis of indications, results, and complications. Eur Urol (2009) 1.70
Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer (2008) 1.64
Trends in regionalization of adrenalectomy to higher volume surgical centers. J Urol (2012) 1.64
Natural history, growth kinetics, and outcomes of untreated clinically localized renal tumors under active surveillance. Cancer (2009) 1.60
Enhancing renal masses with zero net growth during active surveillance. J Urol (2007) 1.59
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. Int J Radiat Oncol Biol Phys (2005) 1.57
Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology (2012) 1.54
Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res (2006) 1.49
Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment. Urology (2013) 1.49
Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol (2002) 1.48
Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int (2014) 1.47
Utility of the R.E.N.A.L. nephrometry scoring system in objectifying treatment decision-making of the enhancing renal mass. Urology (2011) 1.46
Robot-assisted partial nephrectomy: a large single-institutional experience. Urology (2010) 1.45
Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Can J Urol (2012) 1.45
Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol (2010) 1.44
Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. BJU Int (2013) 1.41
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Med Care (2015) 1.41
Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma. J Urol (2012) 1.40
The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy. Can J Urol (2017) 1.39
How Hugh Hampton Young's treatment of President Woodrow Wilson's urinary retention and urosepsis affected the resolution of World War I. J Urol (2011) 1.38
The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer (2004) 1.38
Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis. J Urol (2008) 1.37
Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila) (2009) 1.36
Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy. BJU Int (2011) 1.31
Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol (2007) 1.28
Prostate cancer radiotherapy dose response: an update of the fox chase experience. J Urol (2004) 1.26
Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol (2006) 1.23
Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin Cancer Res (2004) 1.22
Contemporary management of small renal masses. Eur Urol (2011) 1.19
Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer (2007) 1.18
A review of contemporary data on surgically resected renal masses--benign or malignant? Urology (2013) 1.15
Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Res (2003) 1.13
Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin Cancer Res (2008) 1.12
Predicting growth of solid renal masses under active surveillance. Urol Oncol (2008) 1.11
Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel. Cancer (2006) 1.10
Modulation of Akt/mTOR signaling overcomes sunitinib resistance in renal and prostate cancer cells. Mol Cancer Ther (2012) 1.09
Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World J Urol (2003) 1.06
PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection. Cancer Immunol Res (2013) 1.06
Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. J Natl Compr Canc Netw (2009) 1.05
Tumor size predicts synchronous metastatic renal cell carcinoma: implications for surveillance of small renal masses. J Urol (2007) 1.05
Age, tumor size and relative survival of patients with localized renal cell carcinoma: a surveillance, epidemiology and end results analysis. J Urol (2008) 1.05
Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int (2009) 1.05
Incidence and management of penetrating renal trauma in patients with multiorgan injury: extended experience at an inner city trauma center. J Urol (2004) 1.04
Serum amino acid levels as a biomarker for renal cell carcinoma. J Urol (2011) 1.02
Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer (2014) 1.02
Radiation dose and late failures in prostate cancer. Int J Radiat Oncol Biol Phys (2006) 1.01
Competing risks of death in patients with localized renal cell carcinoma: a comorbidity based model. J Urol (2012) 1.01
Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions. J Urol (2012) 1.01
Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2005) 1.00
Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate (2012) 1.00
Evaluation and management of the renal mass. Med Clin North Am (2011) 0.99
Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells. Prostate (2013) 0.99
Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma? Cancer (2005) 0.97
Active surveillance: a potential strategy for select patients with small renal masses. Future Oncol (2011) 0.97
Renal masses herniating into the hilum: technical considerations of the "ball-valve phenomenon" during nephron-sparing surgery. Urology (2009) 0.96
Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate (2007) 0.96
Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys (2005) 0.96
Does partial nephrectomy result in a durable overall survival benefit in the Medicare population? J Urol (2012) 0.96
Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma. PLoS One (2011) 0.95
Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells. Gene (2008) 0.95
Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database. Can J Urol (2013) 0.95
Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Oncogene (2005) 0.95
Partial nephrectomy for renal masses ≥ 7 cm: technical, oncological and functional outcomes. BJU Int (2012) 0.94
The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer (2014) 0.94
Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. Int J Radiat Oncol Biol Phys (2005) 0.94
Differential use of partial nephrectomy for intermediate and high complexity tumors may explain variability in reported utilization rates. J Urol (2013) 0.94
The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genet Cytogenet (2004) 0.93
Targeted therapies for kidney cancer in urologic practice. Urol Oncol (2007) 0.93
Effects of increased cross-sectional imaging on the diagnosis and prognosis of adrenocortical carcinoma: analysis of the National Cancer Database. J Urol (2011) 0.92
Should partial nephrectomy be offered to all patients whenever technically feasible? Eur Urol (2011) 0.92
Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy. Cancer (2003) 0.92
The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2007) 0.91
High-grade ureteroscopic biopsy is associated with advanced pathology of upper-tract urothelial carcinoma tumors at definitive surgical resection. J Endourol (2012) 0.91
Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology. Urol Oncol (2012) 0.91
Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol (2011) 0.91
Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate (2008) 0.91
Pathologic concordance of sporadic synchronous bilateral renal masses. Urology (2008) 0.90